Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 5:01 PM ET

Date/Time Source News Release
05/27/2025 08:01 AM EDT GlobeNewswire BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
05/27/2025 07:00 AM EDT GlobeNewswire BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
05/12/2025 07:00 AM EDT GlobeNewswire BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
03/27/2025 07:00 AM EDT GlobeNewswire BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2024
03/11/2025 07:00 AM EDT GlobeNewswire BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
03/07/2025 07:00 AM EST GlobeNewswire BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
03/04/2025 04:15 PM EST GlobeNewswire BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering
03/03/2025 03:33 PM EST GlobeNewswire BioXcel Therapeutics Announces $14 Million Registered Direct Offering
03/03/2025 07:00 AM EST GlobeNewswire BioXcel Therapeutics Announces FDA Closed its Inspection of Site for Phase 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimer's Dementia
02/28/2025 07:00 AM EST GlobeNewswire BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
Page

Additional News

As of June 11, 2025 • 5:01 PM ET

Date/Time Source News Release
05/30/2025 09:10 AM EDT Financial News Media Real-World Deployments Signal AI Healthcare Is Ready for Scale
05/27/2025 07:20 AM EDT SeekingAlpha BioXcel Therapeutics gets extension from Nasdaq to regain compliance
05/19/2025 11:10 AM EDT Baystreet This Natural Killer Treatment Could Help Transform How Cancer is Treated
05/12/2025 08:15 AM EDT Zacks BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
05/12/2025 07:17 AM EDT SeekingAlpha BioXcel Therapeutics GAAP EPS of -$1.50 beats by $1.54, revenue of $0.17M misses by $0.18M
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - BioXcel Therapeutics Inc.
05/06/2025 09:15 AM EDT Zacks Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates
05/05/2025 05:15 PM EDT Zacks Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
04/16/2025 08:23 AM EDT Markets and Headlines WHO and WEF Are Pushing AI in Global Healthcare - What It Means for the Market
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.